Sekisui America Corporation
UEI: FRRHGS9BLS18
Overview
Awardee Type
Parent
(1 child)
Company Description
SEKISUI Diagnostics is a global leader in innovating and developing highly accurate diagnostics and biochemistry products to help improve patient outcomes.
Name
Sekisui America Corporation
Headquarters
Burlington, MA
United States
United States
Most Recent Award
Sept. 20, 2023
Calculating
Federal contract recipient
SEKISUI DIAGNOSTICS LLC
(UEI FRRHGS9BLS18)
is headquartered in Burlington MA.
Its primary registered NAICS is 325413 In-Vitro Diagnostic Substance Manufacturing.
The corporation
was founded in February 2011 and
federally registered in
March 2011.
Federal Award Analysis
Sekisui America Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI WCCBDFNP8KS1 CAGE 6BKB7 instead.
Legal Name
SEKISUI DIAGNOSTICS LLC
UEI
WCCBDFNP8KS1
CAGE Code
6BKB7
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 1, 2011
Initial Registration
March 15, 2011
Last Registration
May 5, 2025
Registration Activation
May 5, 2025
Registration Expiration
May 5, 2026
Fiscal Year End
March 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
Yes